Paulsen v. Abbott Laboratories et al

Plaintiff: Terry Paulsen
Defendant: Abbott Laboratories, Takeda Pharmaceuticals of North America, Inc., Takeda Chemical Industries Inc. and Tap Pharmaceutical Products, Inc.
Case Number: 1:2015cv04144
Filed: May 11, 2015
Court: US District Court for the Northern District of Illinois
Office: Chicago Office
County: XX US, Outside the State of IL
Presiding Judge: Gary Feinerman
Nature of Suit: Personal Injury- Product Liability
Cause of Action: 28:1332
Jury Demanded By: Plaintiff

Available Case Documents

The following documents for this case are available for you to view or download:

Date Filed Document Text
March 19, 2019 Opinion or Order Filing 181 MEMORANDUM OPINION AND ORDER Signed by the Honorable Robert M. Dow, Jr. on 3/19/2019. For the reasons explained above, Defendants' motions [144; 147; 150] are granted in part and denied in part. Pursuant to Federal Rule of Civil Procedu re 12(b)(5), TAP is dismissed from this action with prejudice. With regard to Defendants' motions under Rule 12(b)(6), all Counts 40 against TPUSA as successor in interest to TAP are dismissed with prejudice; all claims but Count II aga inst AbbVie are dismissed; and all claims but Counts II & V against Abbott are dismissed. The Court sets this matter for further status on April 8, 2019 at 10:00 a.m. to set a schedule for limited discovery regarding: (1) when Plaintiff's c laim accrued; (2) whether the second amended complaint as to AbbVie properly relates back under Rule 15(c)(3); and (3) the roles of the remaining defendants vis--vis the manufacturing and development of Lupron. The parties should submit a join t status report and a proposed schedule for limited discovery no later than April 4, 2019. Finally, as an administrative matter, the motion for Rule 11 Sanctions by AbbVie, Abbott, and TPUSA 153 is stricken without prejudice in light of the notice of withdrawal filed on October 30, 2018 180 . Mailed notice(cdh, )
March 27, 2018 Opinion or Order Filing 111 MEMORANDUM OPINION AND ORDER: Signed by the Honorable Robert M. Dow, Jr on 3/27/2018. Mailed notice(ks, )
June 29, 2016 Opinion or Order Filing 65 ORDER: The parties' Joint Motion to Resolve Discovery Dispute 63 is granted. The Court has reviewed the parties' positions as set forth in the Joint Motion and concludes that Defendant Abbott is not required to do anything more in respon ding to Plaintiff's written discovery on the limited issue as to which the District Judge has permitted discovery to go forward in this case concerning Abbott's status as a real party in interest. See attached Statement for further explanation. Signed by the Honorable Jeffrey T. Gilbert on 6/29/2016. Mailed notice(ber, )

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System

Search for this case: Paulsen v. Abbott Laboratories et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Terry Paulsen
Represented By: Martin A. Dolan
Represented By: Alan Scott Levin
Represented By: Tesfaye Tsadik
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Abbott Laboratories
Represented By: Kathryn Leahy Dore
Represented By: June K. Ghezzi
Represented By: Nicole C. Henning
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Takeda Pharmaceuticals of North America, Inc.
Represented By: Kathryn Leahy Dore
Represented By: June K. Ghezzi
Represented By: Nicole C. Henning
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Takeda Chemical Industries Inc.
Represented By: Kathryn Leahy Dore
Represented By: June K. Ghezzi
Represented By: Nicole C. Henning
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Tap Pharmaceutical Products, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?